Company news

Cambridge Nutritional Sciences PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

Confirmation of Results and Investor Presentation

November 15, 2022

Partnership agreement with Software Provider

November 14, 2022

Launch of new all-employee share incentive plan

November 8, 2022

AGM Statement and Notice of Results

October 26, 2022

Scientific Director to present at FIDHC

October 11, 2022

Positive WHO data received for VISITECT® CD4 test

October 5, 2022

Purchase of Shares by Directors

September 16, 2022

Investor presentation and Confirmation of AGM

September 13, 2022

Change of preliminary results date

August 31, 2022

Confirmation of Preliminary Results

August 8, 2022

Completion of Sale of the CD4 Business

August 3, 2022

Payment received

July 11, 2022

Heads of Terms agreed for Sale of CD4 Business

July 4, 2022

Grant of share incentive awards

June 10, 2022

PDMR/Director Dealing

June 8, 2022

Result of General Meeting and Total Voting Rights

June 6, 2022

Result of Open Offer

June 1, 2022

Posting of Circular and Notice of General Meeting

May 13, 2022

Investor presentation

May 6, 2022

Placing, Subscription and Open Offer

May 6, 2022

Update on validation under CTDA legislation

March 11, 2022

Result of General Meeting

March 7, 2022

Confirmation of Sale of Alva business

March 7, 2022

Investor Meeting

February 18, 2022

Fundraising to raise gross proceeds of up to £7m

February 11, 2022

Sale of Alva manufacturing business

February 11, 2022

Speculation regarding a potential fundraise

February 10, 2022

CE-Mark for self-test for VISITECT® COVID-19 test

February 3, 2022

Confirmation of detection of Omicron variant

January 10, 2022

DHSC contract update

December 10, 2021

Update on CTDA Regulations

November 3, 2021

Exercise of Options and Total Voting Rights

November 1, 2021

Partnership with DAM Health and initial LFT order

November 1, 2021

VISITECT COVID antigen self-test submission update

September 6, 2021

Posting of Annual Report & Accounts &Notice of AGM

July 30, 2021

AbC-19 monitors vaccine response to variants

July 27, 2021

AbC-19 rapid antibody test performance evaluation

July 9, 2021

FDA submission for Emergency Use Authorization

July 2, 2021

Statement re. Media Comment

June 15, 2021

Regulatory progress for VISITECT® COVID-19 test

June 8, 2021

Progress update

June 7, 2021

Positive data for COVID-19 antigen test

June 1, 2021

Positive data for Mologic COVID-19 antigen test

May 5, 2021

Launch of VISITECT® COVID-19 Antigen & Update

April 30, 2021

Director/PDMR Shareholding and Total Voting Rights

April 23, 2021

CE-Mark: Mologic COVID19 lateral flow antigen test

March 22, 2021

Statement re. Government press release

March 15, 2021

UK Public Sector Contract disclosure

March 15, 2021

Contract with Screen4

March 2, 2021

UK-RTC statement on AbC-19TM rapid antibody test

February 24, 2021

← Newer news releases · Older news releases →

Calls

The 5 newest of 14 calls. Every call is listed under its year.